The Estée Lauder Companies Inc. (EL) Earnings
The Estée Lauder Companies Inc. is expected to report next earnings on August 19, 2026 (in NaN days), with a consensus EPS estimate of $0.31. EL has beaten EPS estimates in 11 of its last 12 reported quarters (average surprise +32.7% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 1, 2026 | $0.66 | $0.91 | +37.9% | $3.7B | +0.6% |
| Feb 5, 2026 | $0.83 | $0.89 | +6.6% | $4.2B | +0.3% |
| Oct 30, 2025 | $0.18 | $0.32 | +82.1% | $3.5B | +2.9% |
| Aug 20, 2025 | $0.09 | $0.09 | +4.3% | $3.4B | +0.4% |
| May 1, 2025 | $0.31 | $0.65 | +107.9% | $3.5B | +1.0% |
| Feb 4, 2025 | $0.31 | $0.62 | +100.0% | $4.0B | +0.7% |
| Oct 31, 2024 | $0.09 | $0.14 | +57.9% | $3.4B | -0.3% |
| Aug 19, 2024 | $0.27 | $0.64 | +135.2% | $3.9B | +1.7% |
| May 1, 2024 | $0.49 | $0.97 | +98.0% | $3.9B | +0.6% |
| Nov 1, 2023 | $-0.20 | $0.11 | +155.0% | $3.5B | -0.5% |
| Aug 18, 2023 | $0.02 | $0.07 | +300.0% | $3.6B | +3.9% |
| May 3, 2023 | $0.51 | $0.47 | -7.8% | $3.8B | +6.2% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q3 FY2026 · May 1, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Today, Estee Lauder raised its fiscal 26 outlook and offered preliminary view on fiscal 27. Third quarter organic sales rose 2%, operating margin expanded, EPS grew 40%. Nine months of fiscal 26: three of four regions grew organically, led by mainland China and priority emerging markets; Americas stabilized. Categories: France rose double-digit, skincare low single digits, hair care stabilized, makeup decline slowed. Action plan priorities: accelerated consumer coverage, delivered transformative innovation, boosted consumer-facing investment, achieved restructuring milestones, established one ELC operating model.
Guidance
Raised fiscal 26 outlook; expects organic sales growth of 3% at high end of prior range, operating margin 10.7% - 11%; EPS range $2.35 - $2.45. Preliminary view on fiscal 27: net sales growth 3% - 5%, operating margin 12.5% - 13%.
Segment performance
For the third quarter, organic sales rose 2%, operating margin expanded significantly, bolstered in part by gross margin expansion, and EPS grew 40%. For the nine months of fiscal 26, three of four regions grew organically, led by high single-digit growth in mainland China and double-digit growth in priority emerging markets. Americas stabilized. Fiscal year to date, France rose double-digit organically, skincare grew low single digits, hair care stabilized and makeup rate of decline slowed.
Risks & headwinds
Disruption in the Middle East negatively impacted third quarter sales growth in UChem by approximately one percentage point; current geopolitical and macroeconomic environment remains uncertain and drives global volatility.
Analyst Q&A
Q: Perspective on long-term margin potential;
A: Stefan discussed margin expansion from 8% to expected 13% by fiscal 27 with leverage from growth and cost efficiencies.
Q: Acceleration in global prestige category;
A: Stefan and Akhil talked about category resilience, emerging market growth, online growth, and market share gain.
Q: Americas growth in FY27;
A: Stefan said expected to turn corner with rebalancing channels and innovation.
Q: UK market strategy;
A: Chris was told UK sequential improvement, emerging markets have double-digit growth.
Q: EBIT margins and duty-free;
A: Bonnie was answered on margin drivers and travel retail improvement.